Lack of KRAS and BRAF Mutation in Renal Cell Carcinoma

被引:29
作者
Gattenloehner, S. [1 ]
Etschmann, B. [1 ]
Riedmiller, H. [2 ]
Mueller-Hermelink, H.-K. [1 ]
机构
[1] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Dept Urol, D-97080 Wurzburg, Germany
关键词
CANCER;
D O I
10.1016/j.eururo.2009.02.024
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1490 / 1491
页数:2
相关论文
共 5 条
[1]  
Gattenlohner S, 2009, NEW ENGL J MED, V360, P835
[2]   K-ras mutations and benefit from cetuximab in advanced colorectal cancer [J].
Karapetis, Christos S. ;
Khambata-Ford, Shirin ;
Jonker, Derek J. ;
O'Callaghan, Chris J. ;
Tu, Dongsheng ;
Tebbutt, Niall C. ;
Simes, R. John ;
Chalchal, Haji ;
Shapiro, Jeremy D. ;
Robitaille, Sonia ;
Price, Timothy J. ;
Shepherd, Lois ;
Au, Heather-Jane ;
Langer, Christiane ;
Moore, Malcolm J. ;
Zalcberg, John R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1757-1765
[3]   Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation? [J].
Langner, C ;
Ratschek, M ;
Rehak, P ;
Schips, L ;
Zigeuner, R .
JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (07) :773-775
[4]   Von Hippel-Lindau Tumor Suppressor Gene Loss in Renal Cell Carcinoma Promotes Oncogenic Epidermal Growth Factor Receptor Signaling via Akt-1 and MEK-1 [J].
Lee, S. Justin ;
Lattouf, Jean-Baptiste ;
Xanthopoulos, Julie ;
Linehan, W. Marston ;
Bottaro, Donald P. ;
Vasselli, James R. .
EUROPEAN UROLOGY, 2008, 54 (04) :845-854
[5]   Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer [J].
Rowinsky, EK ;
Schwartz, GH ;
Gollob, JA ;
Thompson, JA ;
Vogelzang, NJ ;
Figlin, R ;
Bukowski, R ;
Haas, N ;
Lockbaum, P ;
Li, YP ;
Arends, R ;
Foon, KA ;
Schwab, G ;
Dutcher, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :3003-3015